A Literature Review on Proper and Safe Use of Insulin
Keywords:
insulin, Diabetes, methods of use, hyperglycemia, intramuscular injectionsAbstract
The aim of this study is to determine the safe and proper utilization of insulin therapy. Insulin therapy is crucial in saving countless lives and improving the quality of life for many individuals. This literature review covers around 30 research articles from 1990-2024. The study shows that some diabetic patients abuse needles, reusing them 2-20 times. Moreover, needles are discarded in a dangerous manner by some patients. In the methodology section of the study, it was found that only a small percentage of patients mixed their insulin before injection. However, most patients cleaned their hands and injection site before insulin delivery. Also, insulin delivery techniques varied among patients. The utilization of insulin pumps is statistically different in glycemic control. Most participants in the study were over 46, married and female. The optimization of insulin delivery could reduce hyperglycemia, intramuscular injections, and lip hypertrophy. Proper diabetes insulin storage and delivery safety training may also have a significant impact.
References
Liu J-L, Segovia I, Yuan X-L, Gao Z-H. Controversial roles of gut Microbiota-derived short-chain fatty acids (SCFAs) on pancreatic β-cell growth and insulin secretion. Int J Mol Sci. 2020;21(3):910. http://dx.doi.org/10.3390/ijms21030910
Veasey R, Ruf CA, Bogatirsky D, Westerbacka J, Friedrichs A, Abdel-Tawab M, et al. A review of reusable insulin pens and features of TouStar—a new reusable pen with a dedicated cartridge. Diabetol Metab Syndr. 2021;13(1). http://dx.doi.org/10.1186/s13098-021-00763-z
Poudel RS, Shrestha S, Piryani RM, Basyal B, Kaucha K, Adhikari S. Assessment of insulin injection practice among diabetes patients in a tertiary healthcare centre in Nepal: A preliminary study. J Diabetes Res. 2017;2017:1–6. http://dx.doi.org/10.1155/2017/8648316
Kesavadev J, Saboo B, Krishna MB, Krishnan G. Evolution of insulin delivery devices: From syringes, pens, and pumps to DIY artificial pancreas. Diabetes Ther. 2020;11(6):1251–69. http://dx.doi.org/10.1007/s13300-020-00831-z
Najmi U, Haque WZ, Ansari U, Yemane E, Alexander LA, Lee C, et al. Inpatient insulin pen implementation, waste, and potential cost savings: A community hospital experience. J Diabetes Sci Technol. 2021;15(4):741–7. http://dx.doi.org/10.1177/19322968211002514
Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–55. http://dx.doi.org/10.1016/j.mayocp.2016.06.010
Gomez-Peralta F, Abreu C, Fernández-Rubio E, Cotovad L, Pujante P, Gaztambide S, et al. Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: A multicenter randomized clinical trial. Diabetes Care. 2023;46(1):206–8. http://dx.doi.org/10.2337/dc22-0525
Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13. http://dx.doi.org/10.2146/ajhp130169
Cohen MR. Pharmacists’ role in ensuring safe and effective hospital use of insulin. Am J Health Syst Pharm. 2010;67(16_Supplement_8):S17–21. http://dx.doi.org/10.2146/ajhp100173
Jendle J, Ericsson Å, Gundgaard J, Møller JB, Valentine WJ, Hunt B. Smart insulin pens are associated with improved clinical outcomes at lower cost versus standard-of-care treatment of type 1 diabetes in Sweden: A cost-effectiveness analysis. Diabetes Ther. 2021;12(1):373–88. http://dx.doi.org/10.1007/s13300-020-00980-1
Watterson JL, August A, Fourt J, Brettler T. The role of human-centered design in insulin pen innovation and the future of insulin delivery. J Diabetes Sci Technol. 2022;16(3):623–7. http://dx.doi.org/10.1177/19322968211043921
Kassab M. Development of sublingual recombinant human insulin drug delivery system by bioinformatics. J Adv Pharm Res. 2023;7(1):66–76. http://dx.doi.org/10.21608/aprh.2022.161468.1192
Matveyenka M, Rizevsky S, Kurouski D. Elucidation of the effect of phospholipid charge on the rate of insulin aggregation and structure and toxicity of amyloid fibrils. ACS Omega. 2023;8(13):12379–86. http://dx.doi.org/10.1021/acsomega.3c00159
Haines ST, Miklich MA, Rochester-Eyeguokan C. Best practices for safe use of insulin pen devices in hospitals: Recommendations from an expert panel Delphi consensus process. Am J Health Syst Pharm. 2016;73(19_Supplement_5):S4–16. http://dx.doi.org/10.2146/ajhp160416
Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(1). http://dx.doi.org/10.1172/jci142241
Parker N, Coetzee A, van Wyk L, Conradie M. Practical aspects of insulin administration: what the healthcare provider knows. J Endocrinol Metab Diabetes S Afr. 2022;27(3):100–7. http://dx.doi.org/10.1080/16089677.2022.2057692
Bahendeka S, Kaushik R, Swai AB, Otieno F, Bajaj S, Kalra S, et al. EADSG guidelines: Insulin storage and optimisation of injection technique in diabetes management. Diabetes Ther. 2019;10(2):341–66. http://dx.doi.org/10.1007/s13300-019-0574-x
White MF, Kahn CR. Insulin action at a molecular level – 100 years of progress. Mol Metab. 2021;52(101304):101304. http://dx.doi.org/10.1016/j.molmet.2021.101304
Steenkamp D, Eby EL, Gulati N, Liao B. Adherence and persistence to insulin therapy in people with diabetes: Impact of connected insulin pen delivery ecosystem. J Diabetes Sci Technol. 2022;16(4):995–1002. http://dx.doi.org/10.1177/1932296821997923
Galindo RJ, Ramos C, Cardona S, Vellanki P, Davis GM, Oladejo O, et al. Efficacy of a smart insulin pen cap for the management of patients with uncontrolled type 2 diabetes: A randomized cross-over trial. J Diabetes Sci Technol. 2023;17(1):201–7. http://dx.doi.org/10.1177/19322968211033837
Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549–64. http://dx.doi.org/10.1161/circresaha.119.315896
Heinemann L, Schnell O, Gehr B, Schloot NC, Görgens SW, Görgen C. Digital diabetes management: A literature review of smart insulin pens. J Diabetes Sci Technol. 2022;16(3):587–95. http://dx.doi.org/10.1177/1932296820983863
Insulin. RCSB: PDB-101. [cited 2024 Dec 11]. https://pdb101.rcsb.org/global-health/diabetes-mellitus/drugs/insulin/insulin
Published on: 11-12-2024
Also Available On
How to Cite
Issue
Section
License
Copyright (c) 2024 Rajia Sultana Nijhu, Susmita Saha
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors contributing to this journal retain the copyright of their article but agree to publish their articles under the terms of the Creative Commons CC-BY 4.0 License (http://creativecommons.org/licenses/by/4.0/) allowing third parties to copy and redistribute the material in any medium or format, and to remix, transform, and build upon the material, for any purpose, even commercially, under the condition that appropriate credit is given, that a link to the license is provided, and that they indicate if changes were made. They may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
